As of May 31, 2025, Taxus Pharmaceuticals Holdings Inc (TXSP) reports a Current Ratio of 0.09.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Taxus Pharmaceuticals Holdings Inc's Current Ratio
Over recent years, Taxus Pharmaceuticals Holdings Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2017-06-30 | 0.09 |
| 2016-06-30 | 0.70 |
| 2015-06-30 | 1.29 |
| 2014-06-30 | 0.61 |
| 2013-06-30 | 1.82 |
This gradual decrease highlights how Taxus Pharmaceuticals Holdings Inc manages its short-term assets and liabilities over time.
Comparing Taxus Pharmaceuticals Holdings Inc's Current Ratio to Peers
To better understand Taxus Pharmaceuticals Holdings Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Taxus Pharmaceuticals Holdings Inc (TXSP) | 0.09 |
| Bowlin Travel Centers Inc (BWTL) | 4.98 |
| Envela Corp (ELA) | 4.12 |
| Nebraska Book Holdings Inc (NEEB) | 3.43 |
| DAVIDsTEA Inc (DTEA) | 3.16 |
| Western Capital Resources Inc (WCRS) | 3.10 |
Compared to its competitors, Taxus Pharmaceuticals Holdings Inc's Current Ratio is lower than all peers, suggesting tighter liquidity management or potential short-term obligations concerns.